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Canine  visceral  leishmaniosis  (CVL)  causes  a  dependent-stage  alteration  in  neutrophil
oxidative  metabolism.  When  production  of  reactive  oxygen  species  (ROS)  exceeds  the
antioxidant  capacity  of  neutrophils,  apoptosis  is triggered,  impairing  the  viability  and
function  of  these  cells,  which  can  predispose  dogs  to infection.  However,  the  uremic
condition  observed  in late-stage  CVL  can  also  alter  the  viability  and  function  of human
neutrophils.  To  more  clearly  understand  this  relationship,  the  apoptosis  rate  and  oxidative
metabolism  of neutrophils  from  control  dogs  (n  =  20)  were  compared  to dogs  in  moder-
ate (n  =  15)  and  very  severe  (n = 15)  stage  CVL,  classiﬁed  according  to LeishVet  Consensus.
To  assess  neutrophil  oxidative  metabolism,  superoxide  production  was  measured  using
the  nitroblue  tetrazolium  reduction  test  (NBT)  in  isolated  neutrophils.  The  apoptosis  rate
of  neutrophils  was  estimated  using  the  morphological  method.  Moderate-stage  dogs  pre-
sented increased  superoxide  production,  while  dogs  with  very  severe  stage  CVL  presented
decreased  superoxide  production  and  an  increase  neutrophil  apoptosis  rate.  Leishmaniosis
causes  differential  neutrophil  dysfunction  according  to  disease  stage.  In  moderate  stage
CVL,  increased  superoxide  production  is observed  with  no  change  in  neutrophil  viabil-
ity. However,  in very  severe  stage  CVL,  decreased  superoxide  production  and  increased
apoptosis  occur  associated  with  uremia.. Introduction
Neutrophils are the main effector cells in mammalian
nnate immunity, conducting the initial defense against
nvading microorganisms. Once recruited and activated by
hemical mediators, neutrophils exert their microbicidal
unction through destroying invading pathogens follow-
ng phagocytosis and the liberation of proteolytic enzymes
nd reactive oxygen species (ROS) produced from the
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superoxide anion (Borregaard et al., 2007). In addition,
these cells link innate and adaptive immunity and partici-
pate in the resolution of inﬂammation (Nathan, 2006).
When adequately stimulated, neutrophils rapidly
respond with ROS production, mainly primed cells
(Hostetter, 2012). However, when ROS production exceeds
the antioxidant capacity of the cell, cellular structures
are oxidized and apoptosis is initiated due to oxidative
stress. Once apoptosis is trigged, impairment of cell func-
tion occurs that diminishes the phagocytic capacity and
oxidative metabolism of neutrophils (Anwar and Whyte,
2007).
Certain microorganisms can modify the oxidative
metabolism and apoptosis of neutrophils and these mech-
anisms have been highlighted as a key component in the
inary PaB.F.M. Almeida et al. / Veter
evasion of the immune system (Anwar and Whyte, 2007).
Among these microorganisms, parasites like Leishmania
spp. have been studied in human models due to their abil-
ity in inhibit the oxidative metabolism (Laufs et al., 2002)
and apoptosis of parasitized neutrophils (Aga et al., 2002).
As the ﬁrst cells to arrive in infection site, neutrophils serve
as “Trojan horses” in the initial phase of infection, shelter-
ing the protozoan until monocytes arrive, so the parasite
can enter in the target cell, without activating oxidative
metabolism (Sunderkötter et al., 1993; Laskay et al., 2003).
Although the role of neutrophils in the establishment of
infection is already known, studies concerning neutrophil
function in canine visceral leishmaniosis (CVL) are scarce
and contain contradictions. In vitro, Leishmania spp. is able
to survive in nonlytic compartments of canine neutrophils
and can also delay cellular apoptosis (Gueirard et al., 2008).
In vivo, Brandonisio et al. (1996) and Vuotto et al. (2000)
observed decreased oxidative metabolism, in which neu-
trophils from infected dogs showed a reduced capacity to
respond to stimulus compared with neutrophils from unin-
fected dogs.
In contrast, Gómez-Ochoa et al. (2010) and Ciarlini
et al. (2010) observed increased superoxide production in
neutrophils from dogs with CVL using the nitroblue tetra-
zolium reduction test (NBT). It is believed that the increase
in neutrophil oxidative metabolism of infected animals is
related to the proﬁle of inﬂammatory mediators produced
by asymptomatic and resistant dogs (Pinelli et al., 1994).
Malafaia and Rezende (2009) highlighted the impor-
tance of evaluating neutrophil function in different stages
of CVL. Thus, Gómez-Ochoa et al. (2010) suggested that
alterations in neutrophil oxidative metabolism are depend-
ent on the stage of disease, with increased superoxide
production in early stages and a discrete decrease in the
end stages of leishmaniosis, a factor that could predispose
dogs with this condition to other infections.
The NBT is used to measure the metabolic activity
of mammalian and microbial cells, such as neutrophils
(Berridge et al., 2005). The NBT has been widely used to
diagnose chronic granulomatous disease in humans. In this
condition, neutrophils do not produce superoxide due to a
failure in enzyme production, causing recurrent infections
(Babior et al., 1973). Currently, NBT is being used in sev-
eral species to assess not only the oxidative metabolism
of neutrophils, but also its diagnostic potential for several
infectious diseases, including leishmaniosis (Gómez-Ochoa
et al., 2010, 2012; Hasegawa et al., 2005; Strasser et al.,
2003).
Considering that the oxidative stress demonstrated in
CVL (Bildik et al., 2004; Heidarpour et al., 2012) could be
due to excessive production of ROS by neutrophils (Gómez-
Ochoa et al., 2010) and this oxidative stress can cause
neutrophil apoptosis, evaluation of neutrophil apoptosis
is essential, since apoptotic neutrophils present functional
impairment and this could predispose infected dogs to
coinfections (Anwar and Whyte, 2007). Until now, stud-
ies evaluating the rate of neutrophil apoptosis in different
stages of CVL have not yet been conducted.
It is believed that the apoptosis observed during oxida-
tive stress is triggered by the activation of caspases (Curtin
et al., 2002). Oxidative stress has also been demonstrated inrasitology 196 (2013) 6– 12 7
humans with uremia (Johnson-Davis et al., 2011), a com-
mon  condition in late-stage leishmaniosis, together with
higher rates of neutrophil apoptosis in uremic patients
(Cohen et al., 2001). The relationships between oxidative
stress, superoxide production and neutrophil apoptosis in
dogs with CVL require more thorough investigation.
Evaluation of neutrophil apoptosis can be performed
following the incubation of cells using light microscopy, in
which speciﬁc morphological changes in the process can
be observed, such as vacuolated cytoplasm and densely
condensed nuclei due to nuclear chromatin condensation
and pyknosis, following the formation of apoptotic bodies.
These alterations are not observed in mature and circulat-
ing neutrophils, making this a reliable method of assessing
apoptosis (Savill et al., 1989).
In CVL, polysymptomatic late-stage dogs are frequently
coinfected by other pathogens (Feitosa et al., 2000;
Andreotti et al., 2006) and usually present a uremic con-
dition due to chronic kidney disease (CKD), in contrast to
early-stage dogs (Costa et al., 2003; Zatelli et al., 2003).
Recent evidences demonstrated that uremic toxins com-
promise neutrophil function in dogs (Barbosa et al., 2010),
a condition similar to that observed in dogs with late-
stage CVL. Other authors have also reported neutrophil
dysfunction in humans (Cendoroglo et al., 1999) and cats
(Keegan and Webb, 2010) presenting a uremic condition,
which could similarly compromise their innate immunity.
To more clearly understand whether the uremic condition
observed in the late stages of CVL compromise neutrophil
function, the present study aimed to compare the apopto-
sis rate and oxidative metabolism of neutrophils from dogs
with leishmaniosis presenting moderate and very severe
stages of the disease.
2. Material and methods
The study was performed in accordance with the ethical
principles concerning the use of experimental animals out-
lined by the Ethics Committee on Animal Experimentation
of São Paulo State University (UNESP), under protocol no.
FOA-9678/10.
According to clinical examinations, 50 adult mixed
breed dogs (2–8 years) were selected and divided into three
groups: Control, comprising 20 healthy dogs, 10 females
and 10 males age from 2 to 4 years-old; Leish II (n = 15),
comprising 8 males and 7 females, all with moderate stage
leishmaniosis, presenting mainly onychogryphosis, lym-
phadenopathy, skin lesions and anemia with no alteration
in renal function; Leish IV (n = 15), comprising 9 males
and 6 females with very severe disease, presenting typ-
ical signs that included lymphadenopathy, skin lesions,
evidence of bleeding, non-regenerative anemia, hyperglob-
ulinemia, hypoalbuminemia and uremia due to CKD (stages
III and IV according to IRIS guidelines; IRIS, 2006).
The dogs were classiﬁed as presenting moderate or
very severe leishmaniosis according to the guidelines of
the LeishVet Consensus (Solano-Gallego et al., 2009). The
amastigote form of Leishmania spp. was  detected in all dogs
in the direct parasitological examination from popliteal
lymph node aspiration and all animals were also positive
in serology by the ELISA test (Lima et al., 2003). Healthy
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ogs were negative in both parasitological examination of
opliteal lymph node specimens and serological ELISA test
Lima et al., 2003) and showed no alteration in physical
nd laboratorial examinations (blood count, urinalysis and
lasma biochemical proﬁle). Dogs with other infections or
ecently treated with drugs capable of altering neutrophil
unction were not selected for the study.
Prior to blood collection the dogs were fasted for 8
o 12 h before 10 mL  of blood were extracted via jugular
enipuncture, 9 mL  were collected in heparinized tubes for
eutrophil isolation and to obtain plasma for biochemical
nalyzes. Another 1 mL  of EDTA-treated blood was used for
omplete blood count.
Biochemical analyses were performed in an automated
pectrophotometer using commercial reagents (BTS 370
lus, Biosystems, Barcelona, Spain) that was previously
alibrated with commercial calibrator. All reactions were
onitored with control serum level I and II (Biosys-
ems, Barcelona, Spain). Biochemical concentrations were
etermined as follows: plasma urea concentration using
rease/glutamate dehydrogenase coupled with the UV
nzymatic assay; plasma and urinary creatinine using the
lkaline picrate kinetic assay; albumin using the bromocre-
ol green assay; total protein using the biuret assay;
holesterol using the oxidase/peroxidase enzymatic assay;
nd urinary protein using the pyrogallol red assay. All bio-
hemical tests were performed at 37 ◦C, in accordance with
he manufacturer’s recommendations.
Blood cell counts were performed in a veterinary
utomated cell count (BC-2800Vet, Shenzhen Mindray
io-Medical Eletronics Co., Nanshan, China). Urine was
ollected by cystocentesis for urine examination and
etermination of the protein/creatinine ratio (UPC) in
rinary supernatant. Urinary density was obtained by
efractometry, chemical examination was performed
sing commercial reagent strips (Combur10 test®, Roche,
annheim, Germany) and analysis of urinary sediment fol-
owed the criteria proposed by Osborne et al. (1995).
Neutrophils were isolated by the Histopaque-
077/1119 (Sigma–Aldrich Co., St. Louis, USA) double
ensity gradient technique (Silva et al., 2013). To achieve
his, 4 mL  of heparinized blood were transferred to sterile
olypropylene conical tubes containing a double gra-
ient separation composed of equal volumes (3 mL)  of
istopaque-1119® and 1077®. Following centrifugation at
40 g for 30 min, the layer of polymorphonuclear (PMN)
ells was aspirated and washed twice with 0.14 M aqueous
mmonium chloride for complete lysis of residual erythro-
ytes. Next, the sample was centrifuged at 100 × g for 5 min
n Hanks’ balanced salt solution (HBSS) (Sigma–Aldrich
o., St. Louis, USA) without Ca2+ and Mg2+ and 1 mL  of
PMI 1640 (Sigma–Aldrich Co., St. Louis, USA) was added
o the cell sediment. Cell concentration was determined
n a hemocytometer and cell viability was estimated
y the blue trypan dye exclusion method. The sample
f isolated PMN  was diluted in RPMI 1640 to obtain a
nal cell concentration of 106/mL, with the purity and
iability of neutrophils equal to or more than 93 and 95%,
espectively.
To evaluate neutrophil oxidative metabolism, super-
xide production was estimated by the NBT according toasitology 196 (2013) 6– 12
the method of Poli et al. (1973) and modiﬁed by Ciarlini
et al. (2010). Brieﬂy, 100 L of cell suspension (106/mL)
were incubated with 50 L of 0.2% saline NBT solution
(Sigma–Aldrich Co., St. Louis, USA) in the presence or
absence of 1 L of a 16.2 M solution of phorbol 12-
myristate 13-acetate (PMA) to perform the stimulated
assay. Following incubation at 37 ◦C and room tempera-
ture, both for 10 min, samples were cytocentrifuged and
stained with hematological dye. The percentage of NBT-
reducing neutrophils was  established after counting at
least 100 neutrophils. Positive cells were considered those
that presented a blackish-blue precipitate typical of form-
azan formation.
To determine the neutrophil apoptosis rate, morpho-
metric analysis of apoptotic neutrophils followed the
criteria proposed by Savill et al. (1989) with modiﬁcations.
To achieve this, 100 L of cell suspension (106/mL) were
incubated with 100 L of RPMI 1640 (spontaneous assay)
or 100 L of a 310.8 M solution of the inductor camp-
tothecin (Sigma–Aldrich Co., St. Louis, USA) to perform
the induction assay. After 4 h at 37 ◦C in a computerized
thermal shaker (Thermomixer, Eppendorf, Mod. Comfort,
Hamburg, Germany), samples were cytocentrifuged and
stained with hematological dye. To quantify apoptotic cells,
only cells that showed at least three of the following unique
morphological characteristics of the process were consid-
ered: vacuolization of cytoplasm, nuclear condensation,
nuclear fragmentation, cellular fragmentation and forma-
tion of apoptotic bodies. The apoptotic index was  estimated
as the percentage of apoptotic cells by counting at least 100
neutrophils.
After testing variables for normality and homoscedas-
ticity, the Kruskal–Wallis test followed by Dunn’s post hoc
test (spontaneous and induced apoptosis, stimulated NBT)
and ANOVA followed by the Tukey post hoc test (sponta-
neous NBT) were used to investigate differences between
the groups. The tests were performed using statistical soft-
ware (SAS Institute Inc. The SAS System, Release 9.2., Cary
NC, 2008) and the results were considered statistically sig-
niﬁcant when p < 0.05.
3. Results
The main clinical signs and laboratory results of con-
trols and dogs with visceral leishmaniosis are presented in
Table 1.
The clinical and laboratory alterations of dogs with CVL
are similar to those described by Baneth et al. (2008).
Generally, dogs with moderate stage CVL presented lym-
phadenopathy, onychogryphosis and cachexia, while dogs
with very severe stage CVL presented uremic halitosis
and ulcers on the tongue and oral mucosa, clinical signs
typical of uremic syndrome due to CKD. The laboratory
ﬁndings most frequently observed were normocytic and
normochromic anemia, hyperproteinemia with hyperglob-
ulinemia and hypoalbuminemia. Very severe stage dogs
mainly differed from moderate stage dogs regarding the
signs of CKD, such as lower urinary density, persistent
non-regenerative anemia and plasma creatinine levels
compatible with stages III and IV of IRIS guidelines (IRIS,
2006).
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Table 1
Frequency of clinical signs and laboratory results (mean ± standard devia-
tion) of controls and dogs with leishmaniosis presenting moderate (Leish
II)  and very severe (Leish IV) disease stages.
Parameter Control Leish II Leish IV
Clinical signs
Lymphadenopathy Absent 80% 53.3%
Onychogryphosis Absent 73.3% 93.3%
Skin lesions Absent 33.3% 40%
Periocular alopecia Absent 53.3% 20%
Cachexia Absent 40% 93.3%
Uremic halitosis Absent Absent 93.3%
Oral and tongue
ulcerations
Absent Absent 86.6%
Dehydration Absent 20% 93.3%
Laboratory tests
Blood count
PCV (%) 47.7 ± 3.3 27.9 ± 7.5 21.5 ± 10.6
RBC (1012/L) 6.5 ± 0.5 3.87 ± 1.35 3.02 ± 1.54
Hemoglobin (g/dL) 15.9 ± 1.0 9.3 ± 3.2 6.9 ± 3.2
MCV (fL) 73.2 ± 2.9 72.3 ± 3.7 71.6 ± 3.6
MCHC (%) 33.3 ± 0.2 33.5 ± 0.7 32.1 ± 2.41
WBC  (109/L) 9.9 ± 2.6 13.0 ± 7.1 11.0 ± 6.23
Biochemical
Urea (mg/dL) 32.6 ± 8.1 29.0 ± 10.8 263.0 ± 114.6
Creatinine (mg/dL) 1.07 ± 0.16 0.89 ± 0.25 4.43 ± 2.1
Total protein (g/L) 65.8 ± 6.3 79.9 ± 19.0 80.9 ± 17.1
Albumin (g/L) 31.0 ± 1.9 20.8 ± 7.2 22.9 ± 4.1
Globulin (g/L) 34.8 ± 6.0 59.1 ± 18.9 58.0 ± 18.0
Cholesterol
(mg/dL)
178.3 ± 51.4 200.8 ± 46.6 256.7 ± 69.3
Urinalysis
Urinary density 1.043 ± 0.003 1.040 ± 0.009 1.016 ± 0.003
UPC  0.2 ± 0.07 0.8 ± 0.6 3.6 ± 1.5PCV, packed cell volume; RBC, red blood cells; MCV, mean corpuscular
volume; MCHC, mean corpuscular hemoglobin concentration; WBC, white
blood cells; UPC, urinary protein/creatinine ratio.
Leishmaniosis altered both the oxidative metabolism
and apoptosis of neutrophils from positive dogs depending
on the stage of disease (Figs. 1 and 2). Spontaneously, neu-
trophils of dogs with moderate stage CVL (54.77 ± 15.9%)
showed higher superoxide production, while those with
very severe stage CVL (31.6 ± 12.2%) presented a decrease
in superoxide production compared with control dogs
(44.4 ± 13.6%; p < 0.0001) (Fig. 1). When stimulated with
PMA, neutrophil superoxide production increased in both
moderate (82.6 ± 21.4%) and very severe stage dogs
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Fig. 1. Boxplot of neutrophils producing superoxide (%) in controls and dogs wit
disease stages spontaneously and in the presence of PMA-stimulus. Non-coinciderasitology 196 (2013) 6– 12 9
(78.6 ± 30.5%), compared with control dogs (49.9 ± 24.5%;
p = 0.0027) (Fig. 1).
The neutrophil apoptosis rate of dogs with very severe
stage CVL (23.5 ± 7.3%; 46.6 ± 18.8%) was higher than
that observed for neutrophils of control (15.6 ± 5.4%;
32.2 ± 6.4%) and moderate stage dogs (18.4 ± 11.3%;
37.2 ± 17%) in both spontaneous (p = 0.0186) and stimu-
lated (p = 0.0287) trials (Fig. 2).
4. Discussion
In the present study was possible to establish that the
alterations in oxidative metabolism and apoptosis of neu-
trophils were dependent on the stage of disease. Studies
assessing the oxidative metabolism of neutrophils in dogs
with leishmaniosis report different and conﬂicting results.
Some authors have reported inhibition of neutrophil oxida-
tive metabolism (Brandonisio et al., 1996; Vuotto et al.,
2000), while others have described increased production of
superoxide (Ciarlini et al., 2010; Gómez-Ochoa et al., 2010).
In the present study, increased superoxide production in
both spontaneous and stimulated trials was  observed, sim-
ilar to other studies that used NBT (Ciarlini et al., 2010;
Gómez-Ochoa et al., 2010). However, other studies have
found inhibition of oxidative metabolism using chemi-
luminescence (Brandonisio et al., 1996; Vuotto et al., 2000).
In these studies, the stimulated production of superoxide
in neutrophils of dogs with CVL was lower than for unin-
fected dogs, in disagreement with the results of the present
study.
Different results in the assessment of neutrophil oxida-
tive metabolism have been observed in humans and
are probably due to the use of different methodologies
(Cendoroglo et al., 1999). In addition to alternate method-
ologies, Vuotto et al. (2000) and Brandonisio et al. (1996)
did not consider disease stage in their studies, which
could also explain the difference between their results
and those obtained in this study, in which inhibition
of oxidative metabolism occurred in end-stage disease
(Fig. 1). The decrease in oxidative metabolism observed
in very severe stage CVL is likely due to the increased
apoptosis also observed in this stage of the disease
(Fig. 2).
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h leishmaniosis presenting moderate (Leish II) and very severe (Leish IV)
nt letters indicate statistically signiﬁcant differences (p < 0.05).
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pontaneously and in the presence of CAM-induction. Non-coincident let
Similar to this study, Gómez-Ochoa et al. (2010) also
eriﬁed decreased oxidative metabolism in neutrophils
n end-stage CVL; however, the difference determined
y their group was mild and nonsigniﬁcant. According
o Gómez-Ochoa et al. (2010), the increase in oxidative
etabolism during the initial stages of CVL could be
elated to greater production of chemotactic agents, such
s cytokines, in asymptomatic dogs, which activate super-
xide production in these animals, ensuring resistance to
nfection. However, in this study was observed that even
ymptomatic dogs with moderate stage disease showed an
ncrease in oxidative metabolism. Thus, the increased pro-
uction of cytokines associated with resistance to infection
oes not fully justify the increased production of superox-
de.
Further investigation to evaluate the signiﬁcance of acti-
ated neutrophils in the early stages of CVL is required. The
ncrease in neutrophil oxidative metabolism observed in
oderate stage CVL could strengthen the body’s ﬁrst line
f defense, which would prevent the occurrence of coinfec-
ions. However, when neutrophil activation is prolonged,
t can generate oxidative stress and induce neutrophil apo-
tosis, affecting the function of neutrophils and favoring
oinfections that lead to worsening clinical signs of CVL
Kennedy and DeLeo, 2009).
Until now, there are no studies that have evaluated
he apoptosis of neutrophils in dogs in different stages of
VL. In this study was possible to observe that the apo-
tosis rate of neutrophils increased in very severe stage
VL (Fig. 2), which occurs following the activation of oxida-
ive metabolism in earlier stages of the disease (Fig. 1). It
s reasonable to assume that the increased production of
OS resulting from the activation of neutrophil oxidative
etabolism in early stage CVL contributed to the increased
poptosis rate observed in the very severe stage of the dis-
ase, as previously demonstrated (Kannan and Jain, 2000).
n parallel, Bildik et al. (2004) showed that dogs with CVL
xhibit oxidative stress with increased plasma lipid perox-
dation. According to Anwar and Whyte (2007), when the
roduction of ROS exceeds the antioxidant capacity of the
ell, the process of apoptosis is triggered, and once initiated,
he cell becomes less functional. In support of this hypothe-
is, treatments based on antioxidants have generated goods presenting moderate (Leish II) and very severe (Leish IV) disease stages
icate statistically signiﬁcant differences (p < 0.05).
results in human patients with leishmaniosis (Sen et al.,
2000; Paula-Junior et al., 2006).
It is important to consider that increased apoptosis
and decreased superoxide production of neutrophils from
dogs presenting very severe stage CVL occurs concur-
rently with laboratory ﬁndings of uremia due to CKD
(Table 1). Recently, studies have conﬁrmed increased apo-
ptosis (Silva et al., 2013) and inhibition of oxidative
metabolism (Barbosa et al., 2010) in neutrophils from dogs
with uremia. Considering only the uremic condition, with-
out concomitant leishmaniosis, studies have demonstrated
decreased oxidative metabolism in cats (Keegan and Webb,
2010) and humans (Cohen et al., 2011; Hirayama et al.,
2001; Sardenberg et al., 2006). In uremia, the uremic toxins
can induce spontaneous apoptosis in human neutrophils
(Cohen et al., 2001; Jaber et al., 2001; Majewska et al.,
2003). These ﬁndings strengthen the hypothesis that ure-
mia  present in very severe stage CVL contributed to the
inhibition of oxidative metabolism and the increase in neu-
trophil apoptosis.
Cendoroglo et al. (1999) explained that the neutrophil
dysfunction observed in uremia is due to increased oxida-
tive metabolism observed in neutrophils in the early stages
of CKD, in which the oxidizing substances exceed the
antioxidant capacity of the cell. This would increase oxida-
tive stress of the cell, injuring vital cellular structures and
triggering the process of apoptosis, thus compromising the
oxidative metabolism in advanced stages and predisposing
patients with end-stage CKD to infections. This explanation
would also serve to explain, at least in part, the increased
rate of apoptosis observed in neutrophils of dogs with very
severe stage CVL. During the moderate stage of the infec-
tion, activation of neutrophil oxidative metabolism occurs,
leading to the depletion of antioxidant defenses and trigg-
ering neutrophil apoptosis, as observed by the higher rate
of apoptosis and decreased superoxide production in very
severe stage CVL.
It is reasonable to assume that the neutrophil dys-
function observed in this study is due to the sum of
oxidative stress caused by infection and the uremic con-
dition that characterizes very severe stage CVL. Regardless
of the mechanisms involved, this inhibition of oxidative
metabolism and increased apoptosis of neutrophils seems
inary PaB.F.M. Almeida et al. / Veter
to damage the ﬁrst line of defense of the organism, thus
favoring the occurrence of coinfections in later stages of
CVL.
5. Conclusion
The function of neutrophils is altered according to the
stage of canine visceral leishmaniosis. In moderate stage
CVL, increased superoxide production occurs without any
change in neutrophil viability. While in very severe stage
CVL, decreased superoxide production and increased apo-
ptosis occur in association with uremia.
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